Curcumin-loaded nanoemulsions, method of manufacture, and method of preventive treatment using the same

Patent metadata

Field	Value
Publication number	US-11813355-B2
Application number	US-201715856786-A
Country	US
Kind code	B2
Filing date	Dec 28, 2017
Priority date	Dec 30, 2016
Publication date	Nov 14, 2023
Grant date	Nov 14, 2023

Abstract

A oil-in-water curcumin nanoemulsion that includes curcumin dissolved in at least one miscible solvent and encapsulated in an oil core, wherein the oil core also comprises a stabilizer, wherein the oil core forms an organic phase which is dispersed in an aqueous solvent, and wherein the oil core is selected from a pharmaceutically acceptable oil. A method of manufacturing an oil-in-water curcumin nanoemulsion includes dissolving the curcumin in at least one miscible solvent; encapsulating the curcumin in the oil core to produce an organic phase solution; adding the stabilizer to the organic phase solution; dispersing the organic phase solution in the aqueous solvent; and evaporating the mixture. A method of preventing metastatic cancer using an oil-in-water curcumin nanoemulsion by administering an amount of the nanoemulsion topically to an area of an excised primary tumor, and monitoring any reincidence of metastatic cancer in the excised primary tumor area.

First claim

We claim:

1. A topical nanoemulsion composition for topical administration, the composition comprising:
curcumin encapsulated in an oil core,
a stabilizer, and
a dispersing aqueous solvent,
wherein the oil core is selected from a pharmaceutically acceptable oil, including soybean oil, ethyl oleate, ethyl butyrate, ethyl caprylate, caprylic/capric triglyceride, mineral oil, liquid paraffin, medium-chain triglyceride oil, grapeseed oil, or combinations thereof;
the stabilizer is selected from an ionic surfactant, soy lecithin, lecithin, agar, carrageenan, gellan, gelatin, guar gum, sodium alginate, xanthan gum, or combinations thereof;
the aqueous solvent is selected from water;
wherein said nanoemulsion has a particles of particle size between 203 to 231 nm, and a zeta potential between −30 to −36 mV; and,
wherein the nanoemulsion composition is obtained by:
dissolving the curcumin in a miscible solvent selected from acetone, ethanol or combinations thereof;
encapsulating the curcumin in the oil core to produce an organic phase solution;
adding the stabilizer to the organic phase solution;
dispersing the organic phase solution in the aqueous solvent; and
evaporating the mixture until a volume of about 1 ml to about 10 ml remains,

whereby topical administration of the composition treats tumor reincidence, cancer relapse or metastasis after surgery in a subject in need thereof.

2. The nanoemulsion composition of claim 1 , wherein the amount of the pharmaceutically acceptable oil added is about 400 μl to about 800 μl per 100 ml of the aqueous solvent.

3. The nanoemulsion composition of claim 2 , wherein the amount of pharmaceutically acceptable oil added is about 500 μl to about 700 μl per 100 ml of the aqueous solvent.

4. The nanoemulsion composition of claim 1 , wherein at least one dose of said nanoemulsion is applied to the subject in need thereof.

5. The nanoemulsion composition of claim 4 , wherein said topical administration is applied to a body area after intervention by surgery for tumor excision.

6. The nanoemulsion composition of claim 5 , wherein said subject is a mammal.

7. The nanoemulsion composition of claim 6 , wherein said mammal is a human.

Assignees

• Univ Chile

Inventors

• Guerrero Rivera Simón Juan
• Contreras Orellana Pamela Paz
• Díaz García Victor
• Lara Arenas Pablo Alberto
• Cárdenas Oyarzo Areli Marly
• Leyton Campos Lisette
• Kogan Bocian Marcelo Javier
• Quest Andrew F G
• Oyarzún Ampuero Felipe Andrés
• Vivanco Palma Andrea I
• Miranda Miranda Victor Andrés

Classifications

• A61K9/1075 Primary

  Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence) · CPC title

• A61K9/0019

  Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title

• A61K31/12

  Ketones · CPC title

• A61K47/08

  containing oxygen, {e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides} · CPC title

• A61K47/10

  Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title